Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas Pharma Names Americas Ops President | Contract Pharma
Promotions & Moves

Astellas Pharma Names Americas Ops President

Barretto-Ko to lead the company's North and South America operations

Percival Barretto-Ko has been appointed president, Americas Operations, for Astellas US LLC, with responsibility for the company’s North and South America operations. Mr. Barretto-Ko previously served as senior vice president, International Operations. He will be located in Northbrook and reports to president and chief executive officer Kenji Yasukawa.
 
Mr. Barretto-Ko joined Astellas in 2005 to lead Astellas Pharma Europe’s corporate strategy organization. In 2011, he was promoted to senior vice president, corporate strategy and government affairs for Astellas US, where he was responsible for business development, corporate strategy, corporate planning, alliance management, and government affairs. In 2015, he was appointed as senior vice president, International Operations, responsible for Astellas’ operations outside of the U.S. Before joining Astellas, he held senior commercial positions with the Roche Group in the U.S. and UK.
 
“Percival has played a critical role in building and growing our business across our Americas region,” said Mr. Yasukawa. “I am confident his expertise will build upon our strong momentum focusing on patients with innovative science that supports unmet medical needs.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters